OpSens Named to 2022 OTCQX Best 50
24 January 2022OPSENS Named to 2022 OTCQX Best 50 Quebec City, Quebec, January 24, 2022 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, is pleased to announce it has been named to the 2022 OTCQX® Best 50, a ranking of top…
OpSens Announces First Quarter Fiscal 2022 Financial Results
13 January 2022OpSens Announces First Quarter Fiscal 2022 Financial Results Conference call on the results today at 11 a.m. ET Quebec City, Quebec, January 13, 2022 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today reported its results for the first quarter…
OpSens to Host First Quarter FY 2022 Financial Results Conference Call on Thursday, January 13, 2022
6 January 2022OPSENS TO HOST FIRST QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JANUARY 13, 2022 Conference call to be conducted at 11:00 am ET Quebec City, Quebec, January 6, 2022 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology,…